Molecular Endocrinology, Vol 10, 1388-1398, Copyright © 1996 by Endocrine Society

ARTICLES

Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein

KE Weis, K Ekena, JA Thomas, G Lazennec and BS Katzenellenbogen
Department of Molecular and Integrative Physiology, University of Illinois, Urbana 61801, USA.

To better understand structure-activity relationships in the human estrogen receptor (ER), we examined the role of tyrosine 537 in the transcriptional response of the receptor, since this residue is close to a region of the hormone-binding domain shown previously to be important in hormone-dependent transcriptional activity and because this amino acid has been proposed to be a tyrosine kinase phosphorylation site important in the activity of the ER. We substituted five amino acids at this position (alanine, phenylalanine, glutamic acid, lysine, or serine) and screened these mutants for their biological activities in the presence and absence of estradiol. Two of the ER mutants, Y537A and Y537S, displayed estrogen-independent constitutive activity that was approximately 20% or 100%, respectively, of the activity of the wild type receptor with estradiol, when assessed in two different cell backgrounds using three different estrogen- responsive promoters. In some circumstances, the Y537E and Y537K proteins also exhibited some low level of constitutive activity. The constitutive activity of the mutants, as well as their activity in the presence of E2, was fully suppressed by antiestrogen. The extent of interaction of the constitutively active ERs with the steroid receptor coactivator-1 (SRC-1) closely parallel the magnitude of transcriptional activity of the receptor. Whereas wild type ER showed interaction with SRC-1 only in the presence of estrogen, Y537A and Y537S ER showed moderate or full interaction in the absence of ligand, an interaction that was blocked by antiestrogen, and the magnitude of interaction was increased to or remained at 100% upon estradiol treatment, implying that the ability of an ER to associate with SRC-1 is a good indicator of a transcriptionally active conformational state of the receptor. Our findings indicate that tyrosine 537 is in a region important in the ligand regulation of ER transcriptional activity and that the presence of certain amino acids at this position can shift ER into a conformation that is active even without ligand. However, tyrosine is not required at this site for estrogen binding or transcriptional response to estrogen in the systems investigated. Our findings, interpreted in light of the recently published x-ray crystal structure of the ligand-binding domains of three related receptors of the nuclear receptor superfamily, suggest that some of the amino acid substitutions introduced at position 537 may facilitate the shift of helix 12 of the ER into an active conformation and/or allow for differential stabilization of the receptor in its active form.

This article has been cited by other articles:

				J. Bao, C. Cao, X. Zhang, F. Jiang, S. V. Nicosia, and W. Bai Suppression of {beta}-Amyloid Precursor Protein Signaling into the Nucleus by Estrogens Mediated through Complex Formation between the Estrogen Receptor and Fe65 Mol. Cell. Biol., February 15, 2007; 27(4): 1321 - 1333. [Abstract] [Full Text] [PDF]

				C. Punchihewa, A. De Alba, N. Sidell, and D. Yang XR5944: A potent inhibitor of estrogen receptors Mol. Cancer Ther., January 1, 2007; 6(1): 213 - 219. [Abstract] [Full Text] [PDF]

				V. S. Likhite, F. Stossi, K. Kim, B. S. Katzenellenbogen, and J. A. Katzenellenbogen Kinase-Specific Phosphorylation of the Estrogen Receptor Changes Receptor Interactions with Ligand, Deoxyribonucleic Acid, and Coregulators Associated with Alterations in Estrogen and Tamoxifen Activity Mol. Endocrinol., December 1, 2006; 20(12): 3120 - 3132. [Abstract] [Full Text] [PDF]

				M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al. The combination of green tea and tamoxifen is effective against breast cancer Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433. [Abstract] [Full Text] [PDF]

				J. Keay, J. T. Bridgham, and J. W. Thornton The Octopus vulgaris Estrogen Receptor Is a Constitutive Transcriptional Activator: Evolutionary and Functional Implications Endocrinology, August 1, 2006; 147(8): 3861 - 3869. [Abstract] [Full Text] [PDF]

				J. H. Kim, M. H. Lee, B. J. Kim, J. H. Kim, S. J. Han, H. Y. Kim, and M. R Stallcup Role of aspartate 351 in transactivation and active conformation of estrogen receptor {alpha} J. Mol. Endocrinol., December 1, 2005; 35(3): 449 - 464. [Abstract] [Full Text] [PDF]

				J. L. Boerner, M. A. Gibson, E. M. Fox, E. D. Posner, S. J. Parsons, C. M. Silva, and M. A. Shupnik Estrogen Negatively Regulates Epidermal Growth Factor (EGF)-Mediated Signal Transducer and Activator of Transcription 5 Signaling in Human EGF Family Receptor-Overexpressing Breast Cancer Cells Mol. Endocrinol., November 1, 2005; 19(11): 2660 - 2670. [Abstract] [Full Text] [PDF]

				J. Zhang, J. Simisky, F. T. F. Tsai, and D. S. Geller A critical role of helix 3-helix 5 interaction in steroid hormone receptor function PNAS, February 22, 2005; 102(8): 2707 - 2712. [Abstract] [Full Text] [PDF]

				M. H. Herynk and S. A. W. Fuqua Estrogen Receptor Mutations in Human Disease Endocr. Rev., December 1, 2004; 25(6): 869 - 898. [Abstract] [Full Text] [PDF]

				F. Barletta, C.-W. Wong, C. McNally, B. S. Komm, B. Katzenellenbogen, and B. J. Cheskis Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrc Mol. Endocrinol., May 1, 2004; 18(5): 1096 - 1108. [Abstract] [Full Text] [PDF]

				Y. Xu, R. J. Traystman, P. D. Hurn, and M. M. Wang Membrane Restraint of Estrogen Receptor {alpha} Enhances Estrogen-Dependent Nuclear Localization and Genomic Function Mol. Endocrinol., January 1, 2004; 18(1): 86 - 96. [Abstract] [Full Text] [PDF]

				D. Chen, M. J. Lucey, F. Phoenix, J. Lopez-Garcia, S. M. Hart, R. Losson, L. Buluwela, R. C. Coombes, P. Chambon, P. Schar, et al. T:G Mismatch-specific Thymine-DNA Glycosylase Potentiates Transcription of Estrogen-regulated Genes through Direct Interaction with Estrogen Receptor {alpha} J. Biol. Chem., October 3, 2003; 278(40): 38586 - 38592. [Abstract] [Full Text] [PDF]

				L. Li, M. P. Haynes, and J. R. Bender Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells PNAS, April 15, 2003; 100(8): 4807 - 4812. [Abstract] [Full Text] [PDF]

				P. Yi, M. D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ER{alpha} and ER{beta} Mol. Endocrinol., April 1, 2002; 16(4): 674 - 693. [Abstract] [Full Text] [PDF]

				A. Koide, S. Abbatiello, L. Rothgery, and S. Koide Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor PNAS, January 24, 2002; (2002) 32665299. [Abstract] [Full Text] [PDF]

				P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]

				L. J. MARTIN, J. BLANGERO, J. ROGERS, M. C. MAHANEY, J. E. HIXSON, K. D. CAREY, P. A. MORIN, and A. G. COMUZZIE A quantitative trait locus influencing estrogen levels maps to a region homologous to human chromosome 20 Physiol Genomics, March 8, 2001; 5(2): 75 - 80. [Abstract] [Full Text] [PDF]

				W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45. [Abstract] [Full Text]

				A. Schlegel, C. Wang, B. S. Katzenellenbogen, R. G. Pestell, and M. P. Lisanti Caveolin-1 Potentiates Estrogen Receptor alpha (ERalpha ) Signaling. CAVEOLIN-1 DRIVES LIGAND-INDEPENDENT NUCLEAR TRANSLOCATION AND ACTIVATION OF ERalpha J. Biol. Chem., November 19, 1999; 274(47): 33551 - 33556. [Abstract] [Full Text] [PDF]

				A. C. Gee, K. E. Carlson, P. G. V. Martini, B. S. Katzenellenbogen, and J. A. Katzenellenbogen Coactivator Peptides Have a Differential Stabilizing Effect on the Binding of Estrogens and Antiestrogens with the Estrogen Receptor Mol. Endocrinol., November 1, 1999; 13(11): 1912 - 1923. [Abstract] [Full Text]

				T. R. Ediger, W. L. Kraus, E. J. Weinman, and B. S. Katzenellenbogen Estrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor Endocrinology, July 1, 1999; 140(7): 2976 - 2982. [Abstract] [Full Text]

				A. GARCÍA RATO, J. GARCÍA PEDRERO, M. A. MARTÍNEZ, B. DEL RIO, P. S. LAZO, and S. RAMOS Melatonin blocks the activation of estrogen receptor for DNA binding FASEB J, May 1, 1999; 13(8): 857 - 868. [Abstract] [Full Text]

				D. Chen, P. E. Pace, R. C. Coombes, and S. Ali Phosphorylation of Human Estrogen Receptor alpha  by Protein Kinase A Regulates Dimerization Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015. [Abstract] [Full Text] [PDF]

				H. Greschik, J.-M. Wurtz, P. Hublitz, F. Kohler, D. Moras, and R. Schule Characterization of the DNA-Binding and Dimerization Properties of the Nuclear Orphan Receptor Germ Cell Nuclear Factor Mol. Cell. Biol., January 1, 1999; 19(1): 690 - 703. [Abstract] [Full Text] [PDF]

				E. M. McInerney, K. E. Weis, J. Sun, S. Mosselman, and B. S. Katzenellenbogen Transcription Activation by the Human Estrogen Receptor Subtype {beta} (ER{beta}) Studied with ER{beta} and ER{alpha} Receptor Chimeras Endocrinology, November 1, 1998; 139(11): 4513 - 4522. [Abstract] [Full Text] [PDF]

				S.-H. Hong, C.-W. Wong, and M. L. Privalsky Signaling by Tyrosine Kinases Negatively Regulates the Interaction between Transcription Factors and SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) Corepressor Mol. Endocrinol., August 1, 1998; 12(8): 1161 - 1171. [Abstract] [Full Text]

				C. Patrone, E. Gianazza, S. Santagati, P. Agrati, and A. Maggi Divergent Pathways Regulate Ligand-Independent Activation of ER{alpha} in SK-N-BE Neuroblastoma and COS-1 Renal Carcinoma Cells Mol. Endocrinol., June 1, 1998; 12(6): 835 - 841. [Abstract] [Full Text]

				G. Lazennec, T. R. Ediger, L. N. Petz, A. M. Nardulli, and B. S. Katzenellenbogen Mechanistic Aspects of Estrogen Receptor Activation Probed with Constitutively Active Estrogen Receptors: Correlations with DNA and Coregulator Interactions and Receptor Conformational Changes Mol. Endocrinol., August 1, 1997; 11(9): 1375 - 1386. [Abstract] [Full Text]

				A. Koide, S. Abbatiello, L. Rothgery, and S. Koide Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor PNAS, February 5, 2002; 99(3): 1253 - 1258. [Abstract] [Full Text] [PDF]